113 related articles for article (PubMed ID: 3403271)
1. [Chloroquine retinopathy: preventable by monitoring the maximum daily dose].
Ochsendorf FR; Runne U
Hautarzt; 1988 Jun; 39(6):341-2. PubMed ID: 3403271
[TBL] [Abstract][Full Text] [Related]
2. [Chloroquine and hydroxychloroquine: side effect profile of important therapeutic drugs].
Ochsendorf FR; Runne U
Hautarzt; 1991 Mar; 42(3):140-6. PubMed ID: 2055762
[TBL] [Abstract][Full Text] [Related]
3. No evidence for chloroquine-associated retinopathy among missionaries on long-term malaria chemoprophylaxis.
Lange WR; Frankenfield DL; Moriarty-Sheehan M; Contoreggi CS; Frame JD
Am J Trop Med Hyg; 1994 Oct; 51(4):389-92. PubMed ID: 7943562
[TBL] [Abstract][Full Text] [Related]
4. Dose relationships in patients with early chloroquine retinopathy.
Easterbrook M
J Rheumatol; 1987 Jun; 14(3):472-5. PubMed ID: 3625628
[TBL] [Abstract][Full Text] [Related]
5. [Chloroquine retinopathy: avoidable by individualized daily dosing].
Ochsendorf FR; Runne U; Goerz G; Zrenner E
Dtsch Med Wochenschr; 1993 Dec; 118(51-52):1895-8. PubMed ID: 8287780
[No Abstract] [Full Text] [Related]
6. Chloroquine and hydroxychloroquine retinopathy: how to follow affected patients.
Ruiz RS; Saatci OA
Ann Ophthalmol; 1991 Aug; 23(8):290-1. PubMed ID: 1952637
[TBL] [Abstract][Full Text] [Related]
7. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
Aylward JM
J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
[TBL] [Abstract][Full Text] [Related]
8. Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials.
Mackenzie AH
Am J Med; 1983 Jul; 75(1A):40-5. PubMed ID: 6869410
[TBL] [Abstract][Full Text] [Related]
9. Chloroquine: consideration of maximum daily dose (3.5 mg/kg ideal body weight) prevents retinopathy.
Ochsendorf FR; Runne U
Dermatology; 1996; 192(4):382-3. PubMed ID: 8864383
[No Abstract] [Full Text] [Related]
10. Antimalarials in the treatment of rheumatoid arthritis.
Zvaifler NJ
Mod Treat; 1971 Nov; 8(4):769-77. PubMed ID: 4258497
[No Abstract] [Full Text] [Related]
11. Delayed onset chloroquine retinopathy: case report.
Martin LJ; Bergen RL; Dobrow HR
Ann Ophthalmol; 1978 Jun; 10(6):723-6. PubMed ID: 677653
[TBL] [Abstract][Full Text] [Related]
12. Chloroquine retinopathy: is there a safe daily dose?
Marks JS
Ann Rheum Dis; 1982 Feb; 41(1):52-8. PubMed ID: 7065730
[TBL] [Abstract][Full Text] [Related]
13. [Chloroquine maculopathy and prevention of malaria].
Balo KP; Mensah A; Mihluedo H
J Fr Ophtalmol; 1996; 19(12):770-6. PubMed ID: 9033902
[TBL] [Abstract][Full Text] [Related]
14. Ophthaproblem. Chloroquine or hydroxychloroquine retinopathy.
Liu W; Sharma S
Can Fam Physician; 2005 May; 51(5):671, 679-80. PubMed ID: 15934269
[No Abstract] [Full Text] [Related]
15. Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapy.
Bernstein HN
Am J Med; 1983 Jul; 75(1A):25-34. PubMed ID: 6869408
[TBL] [Abstract][Full Text] [Related]
16. [Pediatric form of chloroquine retinopathy].
Cordier J; Raspiller A; Lepori JC
Bull Soc Ophtalmol Fr; 1981; 81(8-9):647-50. PubMed ID: 7318100
[No Abstract] [Full Text] [Related]
17. Retinopathy and antimalarial drugs--the British experience.
Spalton DJ
Lupus; 1996 Jun; 5 Suppl 1():S70-2. PubMed ID: 8803916
[TBL] [Abstract][Full Text] [Related]
18. [Ophthalmologic monitoring in chloroquine therapy].
Eggers I; Krastel H
Klin Monbl Augenheilkd; 1998 Sep; 213(3):aA10. PubMed ID: 9793906
[No Abstract] [Full Text] [Related]
19. [A case of chloroquine retinopathy during malaria prophylaxis in an adult].
Chovet M; Vedy J; Fauxpoint B; Vingtain P
Rev Int Trach Pathol Ocul Trop Subtrop; 1979; 56(3-4):91-8. PubMed ID: 542738
[No Abstract] [Full Text] [Related]
20. Factors associated with chloroquine-induced retinopathy in rheumatic diseases.
Araiza-Casillas R; Cárdenas F; Morales Y; Cardiel MH
Lupus; 2004; 13(2):119-24. PubMed ID: 14995005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
